Evidence map›Paper›PMID 28012068›Full record

ReviewMetabolic brain disease2017

Ammonia toxicity: from head to toe?

Srinivasan Dasarathy, Rajeshwar P Mookerjee, Veronika Rackayova, Vinita Rangroo Thrane, Balasubramaniyan Vairappan, Peter Ott, Christopher F Rose

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Metabolic brain disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06248736 (Description of Lactulose Administration by Balloon Rectal Tube in Severe Hepatic Encephalopathy), which is not on this map. Cited by 115 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 1 pooled it
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06248736 completednot on this mapstarted 2022, after this paper: background citation

Description of Lactulose Administration by Balloon Rectal Tube in Severe Hepatic Encephalopathy

TypeobservationalSponsorUniversity Hospital, GrenobleRan2022 to 2024Enrolled25ConditionsHepatic Encephalopathy
3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 1 synthesis or guideline pooled it, 266 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The role of ammonia in chronic liver disease.Hepatology communications · 2026
    Review
  9. Review
  10. Review
  11. Effect of Ammonia onAntioxidants (Basel, Switzerland) · 2026
    Article
  12. Review
  13. Review
  14. Review
  15. Associations of PMThe Journal of international medical research · 2026
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 6 countries.

Srinivasan DasarathyDepartment of Gastroenterology, Hepatology and Pathobiology, Cleveland Clinic, Cleveland, OH, USA.
Rajeshwar P MookerjeeLiver Failure Group, UCL Institute for Liver and Digestive Health, UCL Medical School, Royal Free Hospital, London, UK.
Veronika RackayovaLaboratory of Functional and Metabolic Imaging, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.
Vinita Rangroo ThraneDepartment of Ophthalmology, Haukeland University Hospital, 5021, Bergen, Norway.
Balasubramaniyan VairappanDepartment of Biochemistry, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Dhanvantri Nagar, Pondicherry, India.
Peter OttDepartment of Medicine V (Hepatology and Gastroenterology), Aarhus, Denmark.
Christopher F RoseHepato-Neuro Laboratory, CRCHUM, Department of Medicine, Université de Montréal, Montréal, Québec, Canada. christopher.rose@umontreal.ca.
Cleveland Clinic · USÉcole Polytechnique Fédérale de Lausanne · CHHaukeland University Hospital · NOJawaharlal Institute of Post Graduate Medical Education and Research · INUniversité de Montréal · CAUniversity College London · GB

Funding

Project Two - Exercise Training Decreases Alcohol Drinking by an FGF21-Dependent MechanismP50AA024333 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI Thomas M McIntyre · 2016 to 2026
$19.6M
Novel Therapies for Alcoholic HepatitisU01AA021893 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI MCCLAIN, CRAIG J., MCCULLOUGH, ARTHUR JOSEPH · 2012 to 2017
$6.0M
Novel mechanism based treatment to improve tissue injury in alcoholic hepatitisR01AA028190 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN, NAGY, LAURA E. · 2020 to 2024
$2.8M
Sarcopenia in cirrhosis is mediated by a hyperammonemic stress responseR01DK113196 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN, HATZOGLOU, MARIA · 2018 to 2021
$2.3M
Mechanisms of Malnutrition in Cirrhosis with Portosystemic ShuntingR01DK083414 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN · 2011 to 2015
$1.8M
Mechanisms of Malnutrition in Cirrhosis with Portosystemic ShuntingR01GM119174 · NIGMS · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN · 2017 to 2020
$1.2M
Alcohol induces muscle autophagy by a novel AMPK independent PI3K mediated mechanR21AA022742 · NIAAA · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN · 2014 to 2015
$410k
Hyperammonemia reduces skeletal muscle protein synthesis via a beta-catenin-cMyc mediated impaired ribosomal biogenesisR21AR071046 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI DASARATHY, SRINIVASAN, DAVULURI, GANGARAO · 2017 to 2018
$399k
NIAAA NIH HHS P50 AA024333NIAAA NIH HHS R01 AA028190NIAAA NIH HHS R21 AA022742NIAAA NIH HHS U01 AA021893NIAMS NIH HHS R21 AR071046NIDDK NIH HHS R01 DK083414NIDDK NIH HHS R01 DK113196NIGMS NIH HHS R01 GM119174
6 · The paper itself

Abstract

Ammonia is diffused and transported across all plasma membranes. This entails that hyperammonemia leads to an increase in ammonia in all organs and tissues. It is known that the toxic ramifications of ammonia primarily touch the brain and cause neurological impairment. However, the deleterious effects of ammonia are not specific to the brain, as the direct effect of increased ammonia (change in pH, membrane potential, metabolism) can occur in any type of cell. Therefore, in the setting of chronic liver disease where multi-organ dysfunction is common, the role of ammonia, only as neurotoxin, is challenged. This review provides insights and evidence that increased ammonia can disturb many organ and cell types and hence lead to dysfunction.

Indexed as

AmmoniaAnimalsBrainBrain ChemistryHepatic EncephalopathyHumansHyperammonemiaMuscle, SkeletalAmmoniaAmmoniaBrainHepatic encephalopathyLiverMuscleToxicity

Identifiers

PMID28012068
PMCPMC8839071
OpenAlexW2562815196

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.